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Inhibition of TRF2 accelerates telomere
attrition and DNA damage in naïve CD4
T cells during HCV infection
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Abstract
T cells play a crucial role in viral clearance and vaccine responses; however, the mechanisms that regulate their
homeostasis during viral infections remain unclear. In this study, we investigated the machineries of T-cell homeostasis
and telomeric DNA damage using a human model of hepatitis C virus (HCV) infection. We found that naïve CD4 T cells
in chronically HCV-infected patients (HCV T cells) were signiﬁcantly reduced due to apoptosis compared with agematched healthy subjects (HSs). These HCV T cells were not only senescent, as demonstrated by overexpression of
aging markers and particularly shortened telomeres; but also DNA damaged, as evidenced by increased dysfunctional
telomere-induced foci (TIF). Mechanistically, the telomere shelterin protein, in particular telomeric repeat binding
factor 2 (TRF2) that functions to protect telomeres from DNA damage, was signiﬁcantly inhibited posttranscriptionally
via the p53-dependent Siah-1a ubiquitination. Importantly, knockdown of TRF2 in healthy T cells resulted in increases
in telomeric DNA damage and T-cell apoptosis, whereas overexpression of TRF2 in HCV T cells alleviated telomeric
DNA damage and T-cell apoptosis. To the best of our knowledge, this is the ﬁrst report revealing that inhibition of
TRF2 promotes T-cell telomere attrition and telomeric DNA damage that accelerates T-cell senescent and apoptotic
programs, which contribute to naïve T-cell loss during viral infection. Thus, restoring the impaired T-cell telomeric
shelterin machinery may offer a new strategy to improve immunotherapy and vaccine response against human viral
diseases.

Introduction
T cells play a pivotal role in controlling viral infection
and vaccine responses; however, the mechanisms underlying T-cell dysfunction that lead to chronic infection and
poor vaccine response remain unclear. Hepatitis C virus
(HCV) is highly efﬁcient at establishing chronic infection,
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thus becoming an excellent model to study the mechanisms of T-cell dysregulation and viral persistence1.
Recently, we and others have found that HCV infection
can accelerate T-cell aging, as evidenced by overexpression of aging markers and attrition of telomeres,
indicating excessive cell proliferative turnover or inadequate telomeric DNA maintenance2–9. Telomeres are
repeating hexameric DNA sequences that are found at
chromosome ends in association with a complex of
shelterin proteins. Telomere integrity is a key feature of
linear chromosomes that preserve genome stability and
function, whereas telomere erosion is a hallmark of cell
senescence that drives cell dysfunction or apoptosis10,11.
Although telomere length is maintained in most cases by
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the telomerase, shelterin is essential to protect telomeres
against unwanted DNA damage response (DDR)12,13.
Shelterin comprises six polypeptides (TRF1, TRF2, RAP1,
TIN2, TPP1, and POT1), of which telomeric repeat
binding factor 2 (TRF2) is a key factor that plays an
essential role in maintaining telomere integrity14. TRF2
also protects chromosome ends against replicative DNA
damage, particularly those that occur due to topological
stress15. Notably, TRF2 expression is increased in a variety
of human cancers; consistently, its downregulation reduces tumorigenicity16,17. The role of TRF2 in reprogramming telomeric DNA damage and remodeling T-cell
homeostasis during viral infection, however, is largely
unknown.
To identify factors that perturb T-cell homeostasis
during viral infection, we have explored the role of TRF2
in protecting telomeric DNA damage and T-cell apoptosis
with a model of HCV infection. We provide evidence
revealing that TRF2 inhibition promotes telomere attrition and DNA damage during HCV infection, rendering
HCV T cells more senescent and apoptotic, thus potentially contributing to the HCV persistence and vaccine
non-responsiveness.

Materials and methods
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PerCP/Cy5 antibodies or isotype controls (BioLegend, San
Diego, CA). CD39-PE and CD57-APC (BioLegend) were
employed to assess senescent status of CD4 T cells. To
determine cell apoptosis, PBMCs were stained with
CD45RA−FITC, CD4-APC along with Annexin V (Av)PE and 7-aminoactinomycin D (7AAD) (BD Biosciences,
San Jose, CA) following the manufacturer’s protocol.
Reactive oxygen species (ROS) were measured using the
2ʹ,7ʹ-Dichloroﬂuorescin Diacetate (DCFDA)−based Cellular ROS Detection Kit (Abcam, Cambridge, MA)
according to manufacturer’s protocol. Flow cytometric
analysis, gating strategy, and background controls were
performed as described previously6.
Flow-FISH

Telomere length was measured by Flow-FISH18. Brieﬂy,
PBMCs were stained with CD4-Alexa-647, and ﬁxed in
Cell Fixation buffer (BioLegend) for 20 min. Cells were
incubated with telomere probe TelC (5ʹ-CCCTAACCCTAACCCTAA-3ʹ)-FITC (0.3 μg probe/mL, PNA Bio,
Newbury Park, CA) at room temperature for 10 min in
the dark and then at 82 °C for 10 min. The cells were
washed with post-hybridization buffer, followed by ﬂow
cytometry buffer, then stained with CD45RA−perCP/
Cy5.5, and analyzed by ﬂow cytometry.

Subjects

The study protocol was approved by the
institutional review board (IRB) of East Tennessee State
University and James H. Quillen VA Medical Center
(ETSU/VA IRB, Johnson City, TN). Written informed
consent was obtained from each patient included in this
study. The study subjects were composed of two
populations: 180 chronically HCV-infected patients and
160 age-matched healthy subjects (HSs). All HCVinfected patients were positive for HCV RNA, prior to
antiviral treatment. HSs, obtained from Physicians
Plasma Alliance (PPA), Gray, TN, were negative for
HBV, HCV, and HIV infection.

RNA isolation and real-time RT-PCR

Total RNA was extracted from 1 × 106 cells using PureLink RNA Mini Kit (Invitrogen, Carlsbad, CA), and complementary DNA was synthesized using High Capacity
cDNA Reverse Transcription Kit (Applied Bio systems,
Foster city, CA) per the manufacturer’s instruction. Quantitative real-time PCR was performed in triplicate as
described previously4. Gene expression was normalized to
GAPDH levels and is presented as fold changes using the 2ΔΔct
method. PCR primer sequences are shown in Table 1.
Western blotting

Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood by Ficoll (GE Healthcare, Piscataway, NJ) density centrifugation. Naïve and memory CD4+
T cells were isolated from PBMCs using the Naïve or
Memory CD4+ T Cell Isolation Kit and a MidiMACS™
Separator (Miltenyi Biotec Inc., Auburn, CA). The isolated
T cells were cultured in RPMI-1640 medium containing
10% fetal bovine serum (Atlanta Biologicals, Flowery Branch,
GA), 100 IU/ml penicillin and 2 mM L-glutamine (Thermo
Scientiﬁc, Logan, Utah) at 37 °C and 5% CO2 atmosphere.

Naïve CD4 T cells (2 × 106) puriﬁed from HCV patients
and HSs were used for western blot as described previously6. Primary and secondary antibodies included
TRF2, TPP1, RAP1, TIN2, γH2AX, phospho-p53ser15,
p21, PARP-1, caspase-3, GAPDH, β-actin (Cell Signaling),
POT1 (R&D System, Minneapolis, MN), TRF1 (Thermo
Fisher), p53, Ub (Santa Cruz, Dallas, Texas), Siah1
(Abcam, Cambridge, MA), and horseradish peroxideconjugated antibody (Cell Signaling). Images were captured using ChemiDoc™ XRS + System (Bio-Rad). Protein
band intensity was quantitated by Image Lab software
(Bio-Rad).

Flow cytometry

Co-immunoprecipitation (Co-IP) and ubiquitination assay

For phenotypic analysis of T cells, PBMCs were stained
with CD3-PE, CD4-APC, CD45RA−FITC, and CD28-

Naïve CD4 T cells (6 × 106) were lysed in ubiquitination
assay buffer supplemented with 0.1% sodium dodecyl

Cell isolation and culture
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Table 1 Primers sequences for quantitative RT-PCR
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siRNA silencing

Naïve CD4 T cells (5 × 106) isolated from HSs were
transfected with 100 nM of Smartpools siRNA targeting
4× sequences on TERF2 open-reading frame or scramble
siRNA control (Dharmacon, Lafayette, CO), using
the Human T Nucelofector Kit and Nucleofector I Device
(Lonza, Allendale, NJ) following the manufacturer’s
instruction. After 72 h, the cells were harvested and analyzed by ﬂow cytometry, western blotting, and confocal
microscopy.

Target gene

Sequence 5′ to 3′

hTERT-F

CCAAGTTCCTGCACTGGCTGA

hTERT-R

TTCCCGATGCTGCCTGACC

TERF1-F

TGCTTTCAGTGGCTCTTCTG

TERF1-R

ATGGAACCCAGCAACAAGAC

TERF2-F

GGTACGGGGACTTCAGACAG

TERF2-R

CGCGACAGACACTGCATAAC

POT1-F

TTCCACTAAAGAGCAGGCAA

Lentivirus transduction

POT-R

TGAAGTTCTTTAAGCCCCCA

TINF2-F

CCAGAAAGGGTTCCCCATAC

TINF2-R

TTTACCAGCAGGTGAAGCAG

TERF2IP-F

TCTTCTTCAGGCAAATCTGGA

For lentiviral packaging, HEK293T cells at 80% conﬂuency were transfected with 2.5 μg of pMD2.G (#
12259), 7.5 μg of psPAX2 (# 12260) (both gifts from Dr.
Didier Trone, Addgene), and 10 μg pWPiR or pWPiRTRF2 plasmids, which contain Internal Ribosome Entry
Site (IRES)-driven Green Fluorescent Protein (GFP) protein expression (generous gifts from Dr. Eric Gibson and
Dr. Vincent Picco) using TransporterTM 5 (Polyscience,
Inc, Warrington, PA) reagent following the manufacturer’s instruction. After 4 days, cells were harvested
and subjected to ﬂow cytometry and western blotting.

TERF2IP-R

CCTCCTCCCAGAAGCTCAA

TPP1-F

TCACCAGATCAGCCACATTC

TPP1-R

GGAAAGACTCTCGGAGCTG

TP53-F

ATGGAGGAGCCGCAGTCAGAT

TP53-R

GCAGCGCCTCACAACCTCCGTC

CDKN1A-F

CGATGGAACTTCGACTTTGTCA

CDKN1A-R

GCACAAGGGTACAAGACAGTG

CDKN2A-F

AGACTTGGGTGGAAGAGGA

CDKN2A-R

TAATCATCACAGCTGTTCGG

GAPDH-F

TGCACCACCAACTGCTTAGC

GAPDH-R

GGCATGGACTGTGGTCATGAG

sulfate (SDS). Equal amount of cell lysates were subjected
to Co-IP assay by adding TRF2 monoclonal antibody or
IgG control, and overnight rotated at 4 °C. Next, 50 μl
protein A/G agarose beads (Santa Cruz) were added to
each sample, incubated at 4 oC for 1.5 h with rotation.
Conjugated beads were washed ﬁve times with ice-cold
ubiquitination assay buffer, then subjected to SDSpolyacrylamide gel electrophoresis and western blot as
described above.
Confocal microscopy

Naïve CD4 T cells were isolated and cultured as
described above, followed by immunoﬂuorescence staining using a method described previously6. Rabbit anti53BP1 (Cell Signaling) and mouse TRF1 (Thermo Fisher)
were used as primary antibodies and anti-rabbit IgGAlexa Fluor 488 and anti-mouse IgG- Alexa Fluor 555
(Invitrogen) were used as secondary antibodies. Then,
cells were washed and mounted with DAPI FluoromountG (SouthernBiotech, Birmingham, AL). Images were
acquired with a confocal laser-scanning inverted microscope (Leica Confocal, Model TCS sp8, Germany).
Ofﬁcial journal of the Cell Death Differentiation Association

Statistics

The data were analyzed using Prism 7 software, and are
presented as mean ± SEM or median with interquartile
range. Comparisons between two groups were made using
unpaired Student’s t-test, or paired Tt-test. Multiple
groups were analyzed by ANOVA, with a Tukey’s test or a
nonparametric Mann–Whitney U-test. P-values < 0.05,
< 0.01, or < 0.001 were considered statistically signiﬁcant
or very signiﬁcant, respectively.

Results
T-cell homeostasis and apoptosis in HCV-infected patients
versus age-matched HS

Dysregulated T-cell homeostasis is a characteristic of
persistent viral infection; however, the mechanisms that
control T-cell homeostasis and virus persistence in
humans remain unclear19. As an initial approach to
identify factors that perturb T-cell homeostasis in HCV
infection, we ﬁrst analyzed total CD4+, naïve
CD4+CD45RA+, and memory CD4+CD45RA− T-cell
subsets in PBMCs isolated from HCV and HS. As
shown in Fig. 1a, although the percentage of total CD4+
T-cell frequencies were similar in HCV patients and HS,
the naïve CD4 T-cell repertoire was signiﬁcantly contracted, whereas memory CD4 T cells expanded, in HCVinfected patients. To exclude the possibility of gating
CD4+ monocytes, we gated on lymphocytes and then
CD3+
T
cells,
followed
by
analysis
of
CD3+CD4+CD45RA+ (naïve) and CD3+CD4+CD45RA−
(memory) T-cell subsets. This analysis yielded the same

Nguyen et al. Cell Death and Disease (2018)9:900
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Fig. 1 T-cell homeostasis and apoptosis in HCV-infected patients versus age-matched HS. a T-cell homeostasis analysis by ﬂow cytometry.
Representative dot plots and summary data for percentages of total CD4+, CD45RA+CD4+ naïve, and CD45RA-CD4+ memory T-cell frequencies
within PBMCs from 24 HCV patients and 24 HSs. Each symbol represents one subject. Data are expressed as mean ± SE. NS nonsigniﬁcant. b T-cell
homeostasis analysis by ﬂow cytometry. PBMCs were ﬁrst gated on lymphocytes, then CD3+ T cells, and subsequently CD4+CD45RA+ naïve and
CD4+CD45RA- memory T cells from 11 HCV patients and 7 HSs. c PBMCs isolated from 14 HCV patients and 11 HSs were analyzed for Av and 7AAD
expression by ﬂow cytometry. Representative dot plots and summary data for the percentages of cell apoptosis are shown. Given the data normality
distribution, total CD4 Av is shown as median with interquartile range, and its P-value was calculated by nonparametric test; naïve and memory T-cell
Av is shown as mean ± SE, P-value was calculated by t-test

results (Fig. 1b). In addition to analyzing CD4 T-cell
frequencies by ﬂow cytometry, we also examined the
absolute CD4 T-cell numbers by purifying naïve CD4
T cells from peripheral blood of HCV patients versus HS.
Base on the isolated PBMCs and the yield of naïve CD4+
T cells, we observed a signiﬁcantly lower number of naïve
CD4 T cells in the blood of HCV patients compared with
HS (Table S1). These ﬁndings of contracted naïve CD4
and expanded memory CD4 T-cell subsets are consistent
with previous reports by us and others6,20 showing
reduced naïve CD4 T cells, suggesting a state of cell
activation/differentiation followed by exhaustion/senescence in patients with chronic HCV infection.
The total size of the T-cell repertoire is well maintained
by a ﬁne balance between inﬂux of newly generated T cells
from the thymus, efﬂux by consumption of programmed
cell death, and self-replication within the existing pool of
lymphocytes21. With deﬁcient inﬂux from the thymus in
adults, the immune system reacts by expanding existing
T cells, leading to increased proliferative turnover, cell
senescence, and ultimately, cell apoptosis21. To explore the
contribution of apoptosis to T-cell homeostasis during
Ofﬁcial journal of the Cell Death Differentiation Association

HCV infection, PBMCs derived from HCV patients were
compared with HS for the expression of Av and 7AAD. As
shown in Fig. 1c, Av expression in CD4 T cells revealed an
increased rate of apoptosis in HCV patients in total CD4,
as well as naïve and memory CD4 T cells. Notably, naïve
CD4 T cells were more apoptotic than memory CD4
T cells in HCV patients. This apoptotic susceptibility of
T cells in HCV patients may necessitate compensatory
homeostatic proliferation that can lead to telomere attrition and cell senescence.
T-cell premature senescence in HCV-infected patients
versus age-matched HS

To determine the role of homeostatic proliferation in Tcell senescence, we assessed the aging markers in T cells
from HCV patients and HS. Because loss of CD28
(a T-cell receptor (TCR) co-stimulatory molecule
required for T-cell activation and survival) is considered
an unequivocal marker for T-cell senescence22, we ﬁrst
measured CD28 expression on CD3+CD4+CD45RA+
naïve T cells and CD3+CD4+CD45RA- memory T cells.
As shown in Fig. 2a, we did not observe any difference in

Nguyen et al. Cell Death and Disease (2018)9:900
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Fig. 2 T-cell senescence in HCV-infected patients versus age-matched HS. a CD28 expression on CD3+CD4+CD45RA+ naïve and
CD3+CD4+CD45RA- memory T cells from 11 HCV-infected patients and 7 age-matched HSs. The gating strategy and summary data of the ﬂow
cytometry analysis are shown. Each symbol represents one subject. NS non signiﬁcant. b CD39 expression in T cells from HCV patients and HS. PBMCs
isolated from HCV subjects and HSs were cultured in the presence of anti-CD3/CD28 for 0, 1, 3, 5 days, followed by ﬂow cytometric analysis for CD39
expression on CD4+ T cells. Representative dot plots and summary data are shown. c CD57 expression in naïve T cells from HCV patients and HS.
PBMCs were stimulated with anti-CD3/CD28 for 3 days and then analyzed for CD57 expression on CD4+CD45RA+ naïve T cells isolated from ﬁve HCV
patients and ﬁve HSs. d mRNA expression of CDKN2A (p16), CDKN1A (p21), and TP53 in naïve CD4 T cells isolated from 10 HCV patients and 10 HSs.
The puriﬁed CD4+CD45RO− naïve T cells were analyzed by real-time RT-PCR for p16ink4a, p21cip1, and TP53 mRNA expression. Values were normalized
to GAPDH expression and are presented relative to HS. e Western blot analysis for p53 expression in naïve CD4 T cells isolated from HCV patient and
HS. GAPDH serves as a loading control. Representative WB imaging and summary densitometry data are shown. f Western blot analysis for pp53, p53,
p21 expressions in TCR-stimulated naïve CD4 T cells isolated from HCV patient and HS. β-Actin is used as loading control. Representative WB imaging
and summary densitometry data are shown. g Measurement of ROS level in naïve CD4 T cells. Naïve CD4 T cells were isolated from HCV patients and
HS and subjected to ROS measurement using the DCFDA-based Cellular ROS Detection Kit. Representative overlaid histogram and summary data for
the MFI of DCFDA level in naïve CD4 T cells from HCV patients and HS are shown (n = 4)

CD28 expression on T-cell subsets between HCV patients
and HS. We also measured the expression of CD39 (a cell
surface-located ATPase that identiﬁes terminally differentiated cells23) on CD4 T cells following anti-CD3/
CD28 stimulation for 0, 1, 3, and 5 days. Again, no differences were detected in CD39 expression on either the
resting or TCR-stimulated CD4 T cells in HCV patients
versus HS (Fig. 2b). We next measured the expression
levels of CD57 (also known as human natural killer 1,
HNK1), a glycoprotein expressed on senescent NK or T
lymphocytes24. Remarkably, at day 3 of TCR stimulation,
CD57 expression on CD4+CD45RA+ naïve T cells was
signiﬁcantly increased in HCV patients compared with HS
(Fig. 2c).
To better deﬁne the aging process in naïve T cells
during viral infection, we assessed the aging-associated
cell cycle inhibitors25 including p16ink4a, p21cip1, and p53.
Ofﬁcial journal of the Cell Death Differentiation Association

As shown in Fig. 2d, HCV naïve T cells exhibited higher
mRNA levels of CDKN1A (encodes p21cip1), CDKN2A
(encodes p16ink4a), and p53, as determined by real-time
RT-PCR. Although we could not detect p16ink4a, p21cip1,
and pp53ser15 protein expressions in resting naïve CD4
T cells by western blot, we observed increases in total p53
protein expression in HCV T cells compared with HS
(Fig. 2e). In addition, we found increases in pp53ser15, total
p53, and p21cip1 protein expressions in TCR-stimulated
naïve CD4 T cells from HCV patients (Fig. 2f). We also
examined the expression of aging makers in memory CD4
T cells at both mRNA and protein levels. As shown in
supplemental Fig. S1, we did not observe any difference in
mRNA expression of TP53, CDKN1A, and CDKN2A (Fig.
S1A). However, we observed increases in p53 protein
expression and cleaved poly ADP-ribose polymerase 1
(PARP-1) in unstimulated memory CD4 T cells (Fig. S1B),

Nguyen et al. Cell Death and Disease (2018)9:900

as well as increases in p21 and γH2AX levels in TCRstimulated memory CD4 T cells (Fig. S1C) derived from
HCV patients, suggesting that memory CD4 T cells also
overexpress aging proteins during HCV infection. These
ﬁndings reafﬁrm our previous observations that aging
markers are upregulated in CD4 T cells during chronic
HCV infection3–5,26.
Along with others, we have shown that naïve CD4
T cells are typically resistant to Fas/Fas-L-mediated
apoptosis, pointing to cell internal signals as apoptosis
initiators27. One of the internal stressors linked to cell
apoptosis is damaged DNA, which is particularly important in senescent cells chronically exposed to endogenously generated ROS28. To determine whether ROS can
cause DNA damage and cell apoptosis during viral
infection, we measured the ROS levels in naïve CD4
T cells isolated from HCV and HS by ﬂow cytometry
using the DCFDA, a ﬂuorogenic dye that measures ROS
within the cells29. Indeed, the mean ﬂuorescence intensity
(MFI) of DCFDA was signiﬁcantly increased in naïve
(Fig. 2g), as well as memory (Fig. S1D) CD4 T cells
derived from HCV patients compared with HS, indicating
that ROS generated during infection may play a role in
DNA damage and cell apoptosis.
Telomere attrition and DNA damage in T cells from HCV
patients versus age-matched HS

As telomere attrition is a hallmark of cell senescence, we
further characterized T-cell senescence in HCV infection
by determining telomere length in total, naïve and
memory CD4 T cells by Flow-FISH. As shown in Fig. 3a,
telomere length was signiﬁcantly shortened in HCVderived total CD4 T cells, as well as in naïve and memory
CD4 T cells compared with HS. In addition, telomere loss
was observed in activated CD4 T cells following TCR
stimulation for 3 days.
As mammalian telomeres consist of plentiful triple
guanine repeats (TTAGGG) that are very sensitive to
oxidative DNA damage, we speculate that telomeres in
HCV T cells are not only shortened, but more importantly, DNA damaged. Notably, following genotoxic
insult, 53BP1 is recruited to the DNA damage site and
acts as a docking station for other adaptor proteins to
form microscopically visible nuclear foci (DNA damage
foci)30. Thus, identifying dysfunctional telomere-induced
foci (TIF) is typically regarded as a hallmark of telomeric
DDR30. To determine telomeric DNA damage in T cells
during HCV infection, we compared the number of TIFs
per nucleus and the percentages of cells with > 3 TIFs by
examining the colocalization of 53BP1/TRF1 using confocal microscopy31,32. As shown in Fig. 3b, the number of
TIF per nucleus, as well as the percentage of T cells with
> 3 TIFs were signiﬁcantly higher in CD4 T cells derived
from HCV patients compared with HS. These results
Ofﬁcial journal of the Cell Death Differentiation Association
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suggest that telomeres in patients with chronic HCV
infection are not only shortened but also sustain DNA
damage, which may cause cell apoptosis, emphasizing the
role of telomere integrity in securing T-cell survival.
Telomeric shelterin proteins in T cells from HCV-infected
patients versus age-matched HS

To determine the cause of telomere attrition in T cells
during HCV infection, we next investigated the integrity
of telomeric shelterin proteins that function to protect
telomeres from unwanted DNA damage12. We ﬁrst
examined their mRNA expression, by real-time RT-PCR,
in T cells isolated from HCV patients and HS. As shown
in Fig. 4a, there were no signiﬁcant difference in their
mRNA levels, except TPP1 that was upregulated in total
CD4 T cells from HCV-infected patients. Notably, TPP1
was also signiﬁcantly upregulated, whereas TRF2, TIN2,
and POT1 slightly elevated, in HCV-derived naïve CD4
T cells without stimulation (Fig. 4b). As changes in
mRNA expression may not necessarily be linear to their
protein levels within the cells, we also examined their
protein levels in naïve CD4 T cells isolated from HCV
patients and HS by western blot. In contrast to their
mRNA transcripts, the TRF2 protein level was signiﬁcantly downregulated, whereas the TRF1, TPP1, and
TIN2 proteins were slightly decreased in HCV T cells
compared with HS (Fig. 4c). Notably, TRF2 protein
inhibition was also observed in total CD4 T cells isolated
from HCV patients compared with HS (Fig. 4d). These
results indicate TRF2 inhibition, at the posttranscriptional
level, in CD4 T cells during HCV infection.
Mechanisms involved in inhibiting TRF2 protein expression
in T cells during HCV infection

As p53-mediated proteasomal degradation via E3 ubiquitin ligase Siah-1a is a major mechanism for regulating
TRF2 protein stability in ﬁbroblasts33, we examined these
proteins by western blot in HCV- and HS-derived naïve
CD4 T cells treated with or without the proteasomal
inhibitor MG132. As shown in Fig. 4e, p53 protein
expression was signiﬁcantly increased in naïve CD4
T cells from HCV patients versus HS, with or without
MG132 treatment. Along with p53 upregulation, the
expression of E3 ubiquitin ligase Siah-1a was also
increased in both MG132-treated and untreated naïve
CD4 T cells derived from HCV patients compared with
HS, which was accompanied by decreases in TRF2
expression. In addition, expression of p21cip1, a p53
downstream cell cycle inhibitor and cell senescence
marker, was signiﬁcantly elevated after the MG132
treatment, especially in HCV-derived naïve CD4 T cells.
Concurrently, the DNA damage marker γH2AX was also
markedly elevated in HCV T cells compared with HS,
regardless of the MG132 treatment. Collectively, these
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Fig. 3 Telomere length and telomeric DNA damage in T cells from HCV patients and HS. a Telomere attrition in CD4 T cells from HCV patients.
PBMCs were isolated from 24 HCV-infected patients and 24 age-matched HSs (with or without TCR stimulation), followed by Flow-FISH analysis for
telomere length in total CD4, naïve and memory CD4 T cells. The gating strategy, overlaid histograms (dashed lane = isotype control; solid lane =
HCV patient; ﬁlled area = HS) and summary data of mean ﬂuorescence intensity (MFI) are shown. Each symbol represents one subject. The relative
MFI of HCV telomere length was normalized by HS. b Telomeric DNA damage in naïve CD4 T cells derived from chronically HCV-infected individuals
versus HS was analyzed by confocal microscopy for colocalization of 53BP1 and TRF1. Representative imaging and summary data for the numbers of
TIFs per nuclear, as well as the percentage of cells with > 3 TIFs are shown (n = 12)

results suggest that TRF2 inhibition is associated with
increases in the p53/Siah-1a signaling in senescent, DNA
damaged T cells during HCV infection.
To further address the possibility of ubiquitin degradation as a mechanism for TRF2 inhibition in T cells
during HCV infection, we examined the ubiquitination of
TRF2 in naïve CD4 T cells with or without MG132
treatment. We performed immunoprecipitation (IP) using
a TRF2 monoclonal antibody and then probed the
immunoprecipitates with both TRF2- and ubiquitinspeciﬁc antibodies. As shown in Fig. 4f, without MG132
treatment, ubiquitinlated TRF2 was signiﬁcantly higher in
HCV T cells, consistent with the lower level of TRF2
before the protein pull-down, compared with HS (lane 2
versus lane 1). These data suggest that ubiquitinationmediated proteasomal degradation of TRF2 occurs in
HCV T cells. We also noticed an increased TRF2 ubiquitination in healthy T cells (lane 3 versus lane 1) by the
MG132 treatment, but this TRF2 ubiquitination did not
increase further in HCV-derived cells (lane 4 versus lane
2), suggesting a highly active TRF2 ubiquitination
machinery in HCV T cells. We found a similar pattern of
ubiquitin probe in naïve CD4 T cells derived from HCV
Ofﬁcial journal of the Cell Death Differentiation Association

and HS, with or without MG132 treatment. Taken together, these data indicate an increased proteasomal
degradation of TRF2 that is associated with the activation
of the p53/Siah-1a ubiquitination pathway in T cells
during HCV infection.
TRF2 plays a key role in protecting telomeres from DNA
damage and T-cell apoptosis

TRF2 is a key factor in telomere protection and chromosomal stability, which are critical for cell survival and
function14,15, but its role in T-cell biology in the setting of
viral infection remains unknown. To elucidate the role of
TRF2 in protecting telomere integrity and T-cell survival,
we knocked down TRF2 in healthy T cells and measured
DNA damage, cell apoptosis, and cell function. As shown
in Fig. 5a, healthy naïve CD4 T cells transfected with
siRNA speciﬁc to TRF2 (siTERF2) exhibited a signiﬁcant
decrease in TRF2 protein expression compared with cells
treated with scramble siRNA. Concurrently, p53 and
γH2AX expressions were remarkably upregulated in the
TRF2 knockdown T cells. Notably, the expression of
caspase-3-dependent cleavage of PARP-1 (an enzyme that
catalyzes the transfer of ADP-ribose onto target proteins
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Fig. 4 Telomere shelterin mRNA and protein levels in T cells from HCV patients and HS. a, b mRNA expression of telomere shelterin proteins in
total CD4 T cells and naïve CD4 T cells. Total CD4 T cells and CD4+CD45RO− naïve CD4 T cells were isolated from 10 HCV patients and 10 HSs. Total
RNA was isolated and analyzed by real-time RT-PCR for shelterin mRNA expression. Values were normalized to GAPDH mRNA and calculated relative
to HS. c Shelterin protein expressions in naïve CD4 T cells isolated from HCV patients and HS. GAPDH is used as loading control. Representative
imaging and summary data for western blot densitometry are shown (n = 9). d TRF2 level in total CD4 T cells from HCV patients and HSs.
Representative imaging and summary data for western blot are shown (n = 4). The HCV densitometry data were ﬁrst normalized to β-actin and then
HS. e Naïve CD4 T cells isolated from HCV and HSs were cultured for 72 h in the presence of DMSO control or proteasome inhibitor MG132 (10 μM)
for the last 4 h, followed by western blot analysis for p53, Siah-1, TRF2, p21, γH2AX expressions. β-Actin serves as loading control. f Proteasomal
degradation of TRF2 through ubiquitin signaling pathway in T lymphocytes during HCV infection. Naïve CD4 T cells isolated from HCV (lanes 2 and 4)
and HS (lanes 1 and 3) were lysed in immunoprecipitation (IP) buffer with 0.1% SDS. Protein concentrations were equalized and small amount of cell
lysates were saved before the pull-down assay (bottom panel) and used as control. The rest of cell lysates were used for IP with TRF2 antibody or IgG
control (lane 5). Immunoprecipitated complexes were pulled-down by protein A/G bead and subjected to immunoblotting with the indicated
antibodies

and plays an important role in maintaining DNA chromosomal stability34) was decreased, whereas its cleaved
form was increased in T cells after TRF2 knockdown.
Correspondingly, caspase-3 was decreased but its cleaved
form was increased, which is in line with the increases in
apoptosis in TRF2 siRNA-treated cells that have increased
p53-mediated DNA damage. Additionally, the numbers of
dysfunctional TIF per nucleus (Fig. 5b) and the percentages of Av+ apoptotic cells were also signiﬁcantly
increased (Fig. 5c), and the IL-2 expression was
substantially decreased in T cells after TRF2 knockdown
(Fig. 5d).
To determine whether reconstitution of TRF2 in T cells
can alleviate the DNA damage and cell apoptosis occurring during HCV infection, we overexpressed TRF2 in
naïve CD4 T cells derived from HCV patients using a
lentiviral expression system. As shown in Fig. 5e, lentivirus-mediated, IRES-driven GFP protein expression was
Ofﬁcial journal of the Cell Death Differentiation Association

observed in T-cell transduced with the pWPiR control
vector and the pWPiR-TRF2 construct, but not in
untransduced cells. Importantly, TRF2 expression was
markedly increased in pWPiR-TRF2-transduced T cells
and was accompanied by a decrease in p53, γH2AX, and
cleaved PARP-1 levels, indicating an alleviation of p53mediated DNA damage. In addition, Av expression was
signiﬁcantly reduced in HCV-derived T cells transduced
by the pWPIR-TRF2. These data demonstrate that telomere uncapping and recapping is critical for DNA
damage and apoptosis, determining T-cell survival and
function.

Discussion
Chronic viral infections are characterized by dysfunctional T cells. Here, we show that homeostatic remodeling
of the T-cell repertoire during HCV infection primarily
affects the naïve T-cell compartment. Speciﬁcally, we ﬁnd
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Fig. 5 TRF2 plays a key role in protecting telomere from DNA damage and T-cell apoptosis. a Representative imaging and summary data of
the western blot analysis for TRF2, p53, γH2AX, PARP-1, and caspase-3 expressions in healthy naïve CD4 T cells transfected with TRF2 siRNA (siTERF2)
and scrambled siRNA control. GAPDH is shown as a loading control. The experiments were performed using naïve CD4 T cells derived from HS (n =
4). b Telomeric DNA damage in naïve healthy CD4 T cells. Cells were transfected with control or TRF2 siRNAs and analyzed by confocal microscopy
for colocalization of 53BP1 and TRF1. Representative imaging and summary data for numbers of TIFs per nuclear, as well as percentage of cells with >
3 TIFs are shown (n = 4). c Summary data for apoptotic death of healthy naïve CD4 T cells transfected with the control and TRF2 siRNA (n = 10). d IL-2
expression in healthy naïve CD4 T cells transfected with the control and TRF2 siRNA. n = 5. e GFP expression in lentivirus-untransduced and
transduced naïve CD4 T cells derived from HCV-infected patients. f Representative western blots showing TRF2, p53, γH2AX, and PARP-1 expressions
in HCV-derived naïve CD4 T cells transduced with control or TRF2-expressing lentivirus. g Percentage of Av+ cells in HCV T cells transduced with
control or TRF2-expressing lentivirus are shown (n = 9)

that naïve CD4 T cells in HCV patients are senescent, as
demonstrated by the overexpression of aging markers,
along with telomere attrition with telomeric DNA damage
due to loss of the TRF2 protection, thus contributing to
increased cell apoptosis. Healthy naïve T cells entered
crisis prematurely upon knockdown of TRF2, as evidenced by increased p53 and γH2AX expression,
accompanied by increases in the cleaved form of PARP-1
and caspase-3. Accordingly, TRF2 silenced T cells
exhibited increased numbers of TIF and apoptosis, concomitant with decreased IL-2 production. In contrast,
overexpression of TRF2 in HCV T cells reduced telomeric
DNA damage and cell apoptosis. We thus conclude that
TRF2 protein inhibition leads to telomere attrition and
telomeric DNA damage that triggers cell apoptosis during
HCV infection. Based on these novel ﬁndings, we propose
a model, as depicted in Fig. 6, where HCV-induced telomere deprotection by TRF2 protein inhibition causes
accumulation of telomeric DNA damage and telomere
Ofﬁcial journal of the Cell Death Differentiation Association

erosion, thus contributing to T-cell apoptosis. Telomere
attrition-mediated T-cell apoptosis may necessitate
homeostatic proliferation and impose replicative stress on
unprimed naïve T cells, further contributing to naïve Tcell loss. This represents a novel molecular mechanism
that underlies T-cell senescence and T-cell loss.
The immune system is in constant turnover during viral
infection, with high demands for lymphocyte replenishment to maintain the T-cell equilibrium. Ongoing antigenic stimulation during chronic viral infection induces
continuous differentiation of naïve T cells and turnover of
antigen-reactive T cells. In this regard, memory T cells
would expand and thus compromise the size and survival
of naïve T-cell repertoire. Our study focused on the naïve
T cells because they represent the reserves of the immune
system, and their survival critically affects the outcome of
immune aging. Undoubtedly, the apoptotic loss of naïve
T cells determines the generation of sufﬁcient antigenspeciﬁc T-cell clones, as well as the cellular yield of
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Fig. 6 A model of HCV-induced TRF2 inhibition, leading to T-cell telomere uncapping and attrition, accelerating cell senescence,
apoptosis, and naïve T-cell loss during HCV infection. HCV infection promotes T-cell activation/proliferation/differentiation and induces TRF2
protein inhibition, which leads to telomere deprotection and triggers DNA damage and telomere erosion, thus contributing to T-cell apoptotic
death. Excessive T-cell apoptosis feedback necessitates homeostatic over-expansion, then cell exhaustion/senescence, imposing replicative stress on
unprimed naïve T cells and further accelerating naïve T-cell loss. This incessant regulatory cascade represents a novel molecular mechanism
underlying T-cell senescence and naïve T-cell loss, which contributes to the viral persistence and vaccine non-responsiveness in human viral infection

homeostatic proliferation, a process that generates new
T cells upon the response to neo-antigens, including
vaccines. Indeed, along with others, we have shown poor
vaccine (HAV, HBV, inﬂuenza, and Pneumovax) responses in the setting of chronic viral (HCV and HIV) infections2,3,35–39. Our new ﬁndings in this study indicate that
naïve helper T cells in HCV patients have aberrant
abnormalities that jeopardize their ability to mount
effective immune (vaccine) responses. In particular, the
naïve T cells compartment is severely contracted, and
naïve CD4 T cells exhibit telomere attrition with damaged
DNA due to the lack of TRF2 protection. Accumulated
DNA damage renders HCV T cells more prone to apoptotic death, thus imposing replicative stress and premature senescence.
A typical feature of T cells in chronic viral infection is
premature aging, characterized by telomere shortening
compared with age-matched HS2–9. In normal primary
T cells, telomeres undergo shortening at a rate of 50–100
base pairs (bp) per cell division, and predictable loss of
telomeric DNA with each cell replication allows telomeres
to serve as molecular clock that controls the replicative
capacity of T cells before entering cell cycle arrest,
senescence, or apoptosis40,41. However, telomere loss can
increase up to 250 bp per cell cycle during chronic viral
infection and, in compensating for this, cell cycle arrest
occurs when progressive telomere loss reaches a critical
point, a phenomenon known as replicative senescence40,41. Based on our studies, we believe that HCVOfﬁcial journal of the Cell Death Differentiation Association

induced naïve CD4 T-cell loss is primarily driven by
ROS-mediated DNA damage and telomere attrition. As
depicted in Fig. 6, in healthy young subjects the telomeres
are intact with shelterin complexes well formed to protect
telomeres from unwanted DNA damage; thus, normal
T cells can proliferate/differentiate efﬁciently in response
to antigen stimulation. However, HCV infection can
induce TRF2 protein degradation via the p53/Siah1mediated ubiquitination, leading to telomere uncapping
and telomeric DNA damage. We believe that HCVinduced TRF2 inhibition, telomere loss, cellular senescence, and apoptosis are sequential but constant events,
that is, if telomeres are mildly or moderately shortening,
the over-expanded cells are exhausted or senescent, and
cell cycles are arrested in the G1 phase to allow for DNA
damage repair. If telomeres are severely shortening to a
critical point that the damaged DNAs are irreparable,
then the cells will undergo suicidal apoptosis and die. This
continuous depletion of naïve CD4 T cells serves as a
mechanism and contributes to the high rates of HCV
persistence and vaccine non-responsiveness in virally
infected individuals.
Several mechanisms may potentially contribute to the
senescence-associated telomere attrition. First, increased
T-cell proliferative turnover can cause cell divisioninduced telomere erosion. Typically, telomere is lost due
to incomplete synthesis of the terminal DNA during cell
division. The enzyme telomerase counteracts telomere
loss by synthesizing telomeric repeats during cell
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proliferation. However, we have found that telomerase
expression and its activity in CD4 T cells were unchanged
or not dramatically suppressed during HCV infection
(unpublished observations), suggesting that other
mechanisms might be involved in telomere attrition. In
our study, we found a signiﬁcant decrease in TRF2 and a
slight decrease in TRF1, TPP1, and TIN2 protein
expressions in HCV T cells. Given that TPP1 and TIN2
are required to bridge the TRF1 and TRF2 complexes for
telomere sheltering42, we speculate that the relative lower
levels of TRF2, TRF1, TPP1, and TIN2 in T cells of HCV
patients could lead to poor sheltering, telomere uncapping or deprotection, and thus ROS-mediated DNA
damage. Additionally, Zhong et al. reported that the
oligonucleotide binding (OB)-fold domain of TPP1
recruits telomerase to telomeres through an association
with Telomerase reverse transcriptase (TERT)43. Reconstitution of shelterin complexes reveals unexpected stoichiometry that can enhance telomerase processivity44. We
thus believe that with decreased shelterin proteins, there
would be insufﬁcient recruitment of telomerase to telomeres for chromosomal end maintenance during HCV
infection. This possibility is under active investigation in
our lab.
Second, telomeres are highly susceptible to DNA
damage. Human naïve T cells have a relatively long life
span (150–160 days) and are exposed to a multitude of
genotoxic stressors, causing 1% of approximately 300
billion T cells to be replaced daily. Their telomeric DNA
is particularly vulnerable to ROS-induced DDR, even
more so than non-telomeric DNA. Plasmid-inserted
human telomeres, for example, accumulate sevenfold
higher strand breakage than control sequences45. In
addition, the frequency of single-strand breaks is severalfold higher in telomeres than in the bulk genome when
cells are exposed to oxidative stress46. In line with these
ﬁndings, we ﬁnd that T cells derived from HCV patient
exhibit not only shortened telomeres, but also damaged
DNA, which can contribute to telomere loss.
Third, an inhibition of protective shelterin proteins may
lead to deprotection of the telomeres. In our study, the
expression of TRF2 is signiﬁcantly inhibited at the protein
level via the p53/Siah-1a-mediated ubiquitin pathway in
naïve CD4 T cells during HCV infection, rendering the
uncapped telomeres prone to DNA damage and cell
apoptosis. T-cell replicative senescence is induced by
uncapped telomeres, which activates DDR and telomere
erosion. T-cell death, however, requires overriding of
senescence through further telomere attrition, concomitant with loss of DNA damage checkpoints, thus
causing cell apoptosis. Notably, TRF2 is a key factor that
plays an essential role in maintaining telomere integrity by
suppressing the ATM-dependent DDR14. Recently, we
have shown that telomere loss in HCV T cells is triggered
Ofﬁcial journal of the Cell Death Differentiation Association
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by DDR and the inability of a timely repair by the ATM
pathway6. Similar to our study, Guo et al.47,48 reported
that ATM activation in response to ROS was independent
of the Mre11-Rad50-Nbs1 complex (MRN) complex.
ROS-mediated ATM signaling represses mammalian target of rapamycin complex 1 (mTORC1) signaling and
therefore cell growth and proliferation through activation
of Tuberous sclerosis complex 2 (TSC2) (a negative regulator of mTOR) by liver kinase B1 and AMP-dependent
kinases49.
ATM
engagement
of
the
TSC2/
mTORC1 signaling pathway can also regulate autophagy50, and differential localization of ATM is correlated
with activation of distinct downstream pathways51. We
have also discovered that KML001, a telomere-targeting
drug, can induce telomeric DNA damage and T-cell
apoptosis by inhibiting TRF2 expression and impairing
the ATM pathway (unpublished observations). Moreover,
inhibition of Topoisomerase I or II by camptothecin or
ICRF-193, which induces topological stress by suppressing telomere TRF2 protection, also exacerbates telomeric
DNA damage and enhances T-cell death (unpublished
observations). In this study, we show that TRF2 silencing
ampliﬁes telomere uncapping, triggers telomeric DNA
damage, and decides cellular fate, suggesting that telomere deprotection via TRF2 inhibition is the underlying
molecular mechanism that causes telomeric DNA damage
and cell apoptosis in HCV infection. It should be pointed
out, however, that the pathogenesis of HCV persistence is
multifaceted, in that not only telomere shelterin proteins
(especially TRF2) are inhibited, but other mechanisms
appear impaired, including DNA repair enzymes (ATM/
ATR), telomerase access to telomeres, and DNA topoisomerases, all of which can work in concert to damage
telomeres and lead to naïve T-cell loss during HCV
infection.
Our ﬁndings of TRF2-mediated telomere uncapping
and T-cell apoptosis during HCV infection are clinically
relevant and highly signiﬁcant. We propose that TRF2
inhibition is the molecular mechanism that controls Tcell life span in the setting of chronic HCV infection. In
line with this, we have recently found that CD4 T cells in
latently HIV-infected individuals are also senescent with
shortened, DNA-damaged telomeres due to TRF2 and
ATM inhibition (unpublished observations). Thus, TRF2mediated telomere attrition and cell apoptosis may
represent a universal mechanism that controls T-cell
homeostasis in chronic viral infections. Importantly, our
results show that reconstitution of TRF2 is necessary and
sufﬁcient to protect telomeres from unwanted DNA
damage and rescue HCV T cells from apoptosis, indicating the importance of TRF2 in telomere protection and
T-cell survival in human infectious diseases.
These ﬁndings might also offer a clinical opportunity for
oncogenesis and anticancer treatment, as cell cycle arrest
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has been associated with tumorigenesis in checkpointcompromised cells52, whereas exacerbation of TRF2mediated telomere deprotection sensitizes cancer cells
to telomere-targeting drugs. Similarly, bone marrow failure and related diseases are often observed in individuals
with telomeropathies, which could potentially be
explained by cell mitotic arrest resulting from excessive
shortened and/or damaged telomeres53,54. Therefore,
TRF2-mediated telomere uncapping and telomere lossdriven cell cycle arrest may have broader implications
through impairing diverse cellular functions.
Telomere integrity is essential to life, as telomere clearly
preserves genomic DNA stability and cell proliferative
potential. Thus, recognizing telomeric DNA damage due
to TRF2 uncapping as a fundamental mechanism of cellular aging will create a new paradigm in cell aging
research. Notably, chronic infection or inﬂammationinduced immunosenescence (i.e., inﬂammaging) may
prove to be a key molecular process that applies to a wide
range of clinical scenarios. Nevertheless, to the best of our
knowledge, this is the ﬁrst report showing that inhibition
of shelterin protein TRF2 promotes T-cell telomere
attrition and telomeric DNA damage to accelerate T-cell
senescence and apoptosis in human viral infection. It
should be noted that while telomere TRF2 uncapping
explains both telomeric DNA damage and cell apoptosis,
it may function as a double-edged sword, resulting in both
an overwhelming cell death in acute infection and
immune tolerance or immune suppression in chronic
infection. Our ﬁndings indicate that appropriate manipulation of telomere/TRF2 shelterin machinery may
restore T-cell competency and prevent premature
immune senescence, thus providing a new strategy to
improve immunotherapy and vaccine responses against
human viral diseases.
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